Early Data Show Neflamapimod’s Potential to Prevent Nerve Cell Degeneration
Huntington's Disease News
Publication date: Jul 30, 2019 This post was originally published on this site Treatment with EIP Pharma’s investigational therapy neflamapimod (VX-745) can restore nerve cells’ communications and prevent their progressive ... Read more